<unk>  is an antineoplastic agent that is FDA approved for the treatment of patients with metastatic colorectal cancer (mCRC) that is resistant to or has progressed following an oxaliplatin-containing regimen. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include angina,hypertension, pseudoaneurysm,hand-foot syndrome ,hyperpigmentation of skin,impaired wound healing.
Ziv-aflibercept
Aflibercept
Toceranib
Ranibizumab
Pazopanib hydrochloride
Vemurafenib
Gilteritinib
Baricitinib